Random intercept hierarchical linear model for multi-regional clinical trials

References

• Blair, J. E., F. Zannad, M. A. Konstam, T. Cook, B. Traver, J. C. Burnett, L. Grinfeld, H. Krasa, A. P. Maggioni, C. Orlandi, et al. 2008. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure: Results from the everest (efficacy of vasopressin antagonism in heart failure: Outcome study with tolvaptan) program. Journal of the American College of Cardiology. 52(20):1640–1648. doi:10.1016/j.jacc.2008.07.056.
   PubMed Web of Science ®Google Scholar
• Carroll, K. J., and T. R. Fleming. 2013. Statistical evaluation and analysis of regional interactions: The PLATO trial case study. Statistics in Biopharmaceutical Research 5 (2):91–101. doi:10.1080/19466315.2013.783878.
   Web of Science ®Google Scholar
• Chen, J., and H. Quan. 2016. Multiregional clinical trials for simultaneous global new drug development. Boca Raton: CRC Press.
   Google Scholar
• CHMP. 2015. Guideline on adjustment for baseline covariates in clinical trials.
   Google Scholar
• Fioletov, V., J. B. Kerr, and A. Fergusson. 2010. The UV index: Definition, distribution and factors affecting it. Canadian Journal of Public Health 101 (4):I5–9. doi:10.1007/BF03405303.
   PubMed Web of Science ®Google Scholar
• Hung, H. J., S. -J. Wang, and R. T. O’Neill. 2010. Consideration of regional difference in design and analysis of multi-regional trials. Pharmaceutical Statistics 9 (3):173–178. doi:10.1002/pst.440.
   PubMed Web of Science ®Google Scholar
• ICH E17. 2017. General principles for planning and design of multiregional clinical trials guidance for industry.
   Google Scholar
• ICH E5. 1998. Ethnic factors in the acceptability of foreign clinical data.
   Google Scholar
• Julious, S., S. B. Tan, and D. Machin. 2010. An introduction to statistics in early phase trials. Oxford: John Wiley & Sons.
   Google Scholar
• Kim, S., and S. -H. Kang. 2020. Hierarchical linear models for multiregional clinical trials. Statistics in Biopharmaceutical Research 12 (3):334–343. doi:10.1080/19466315.2019.1654914.
   Web of Science ®Google Scholar
• Kim, J., and S. -H. Kang. 2022. Hierarchical generalized linear models for ordinal response data in multiregional clinical trials. Statistics in Biopharmaceutical Research. Submitted.
   Google Scholar
• McCulloch, C., S. R. Searle, and J. Neuhaus. 2008. Generalized, linear and mixed models. In Wiley series in probability and statistics, ed. D. J. Balding, N. A. C.Cressie, G. M. Fitzmaurice, I. M.Johnstone, G. Molenberghs, D. W. Scott, A. F. M. Smith, R. S. Tsay, and S. Weisberg, 2nd ed., 72. New Jersey: Wiley.
   Google Scholar
• Ministry of Health, L., and W. of Japan. 2007. Basic principles on global clinical trials.
   Google Scholar
• Morillo, C. A., J. A. Marin-Neto, A. Avezum, S. Sosa-Estani, A. Rassi Jr, F. Rosas, E. Villena, R. Quiroz, R. Bonilla, C. Britto, et al. 2015. Randomized trial of benznidazole for chronic chagas’ cardiomyopathy. The New England Journal of Medicine. 373(14):1295–1306. doi:10.1056/NEJMoa1507574.
   PubMed Web of Science ®Google Scholar
• Morton, C., R. Dominicus, P. Radny, T. Dirschka, A. Hauschild, U. Reinhold, R. Aschoff, M. Ulrich, S. Keohane, S. Ekanayake-Bohlig, et al. 2018. A randomized, multinational, noninferiority, phase iii trial to evaluate the safety and efficacy of bf-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. The British Journal of Dermatology. 179(2):309–319. doi:10.1111/bjd.16441.
   PubMed Web of Science ®Google Scholar
• Park, J., and S. -H. Kang. 2020. Hierarchical generalized linear models for multi-regional clinical trials. Accepted by accepted by Statistics in Biopharmaceutical Research. doi:10.1080/19466315.2020.1862702.
   Google Scholar
• Park, J., S. -H. Kang, and I. H. Jin. 2022. Control of frequentist type 1 error rates in hierarchical linear models for multiregional clinical trials using a bayesian method. Statistics in Biopharmaceutical Research 14 (3):358–367. Accepted subject to major revision. doi:10.1080/19466315.2020.1862702.
   Web of Science ®Google Scholar
• Quan, H., M. Li, W. J. Shih, S. P. Ouyang, J. Chen, J. Zhang, and P. -L. Zhao. 2013. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials. Statistics in Medicine 32 (10):1691–1706. doi:10.1002/sim.5543.
   PubMed Web of Science ®Google Scholar
• Raudenbush, S. W., and A. S. Bryk. 2002. Hierarchical linear models: Applications and data analysis methods, volume 1. Thousand Oaks, California: SAGE.
   Google Scholar
• Song, S. Y., D. Chee, and E. Kim. 2019. Strategic inclusion of regions in multiregional clinical trials. Clinical Trials 16 (1):98–105. doi:10.1177/1740774518813573.
   PubMed Web of Science ®Google Scholar
• Tanaka, Y. 2016. Intrinsic and extrinsic factors and rationales to be considered when defining regions. London: Chapman and Hall/CRC.
   Google Scholar
• Tango, T. 2017. Repeated measures design with generalized linear mixed models for randomized controlled trials. New York: Chapman and Hall/CRC.
   Google Scholar
• United Nations Development Program (2019). International human development indicators. http://hdr.undp.org/en/statistics/.
   Google Scholar